Piper Sandler (PIPR) director granted 59 shares in Form 4 filing
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sterling Brian R reported acquisition or exercise transactions in this Form 4 filing.
Piper Sandler Companies director Brian R. Sterling received a grant of 59 shares of Common Stock on March 13, 2026, as a compensation-related award at no cost. Following this grant, he directly holds 25,584 shares of the company’s common stock.
The related footnote explains that dividend equivalents on phantom stock in the directors’ deferred compensation plan are reinvested into additional phantom shares and will ultimately be paid out in an equal number of common shares after the director’s service ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sterling Brian R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 59 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 25,584 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Piper Sandler (PIPR) director Brian R. Sterling report in this Form 4?
Brian R. Sterling reported receiving 59 shares of Piper Sandler Common Stock as a grant or award. The shares were acquired at no cost and increased his direct holdings to 25,584 common shares, reflecting routine director compensation rather than an open-market transaction.
What does the phantom stock footnote mean in the Piper Sandler (PIPR) Form 4?
The footnote explains that dividend equivalents on phantom stock are reinvested into additional phantom shares within the directors’ deferred compensation plan. These phantom shares become payable in an equal number of common shares on the last day of the year when the director’s service ends.
Is the Piper Sandler (PIPR) Form 4 transaction an open-market buy or a compensation award?
The transaction is a compensation award, not an open-market buy. The Form 4 uses code “A” for a grant or other acquisition, with 59 Common Stock shares received at no cost, reflecting routine director compensation rather than discretionary market purchasing activity.